Ionis is a California-based biotechnology company that researches and develops RNAi-based therapeutics for the treatment of genetic diseases... Read more
Ionis is a California-based biotechnology company that researches and develops RNAi-based therapeutics for the treatment of genetic diseases... Read more
1989
PublicNASDAQIONS
News
Apr 29, 2026
Owler
Ionis Pharmaceuticals, Inc.: Ionis Pharmaceuticals's revenue changed from $943.71M in Dec 2025 to $1.06B in Mar 2026
Apr 28, 2026
Nasdaq
Ionis Pharmaceuticals: FDA Accepts Priority Review And Grants BT Designation For Bepirovirsen In Chronic Hepatitis B
Mar 26, 2026
Benzinga
Ionis Pharmaceuticals: Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market
Mar 09, 2026
Owler
Ionis Pharmaceuticals, Inc.: Ionis Pharmaceuticals's employee count changed from 1.07K in Dec 2024 to 1.40K in Dec 2025
Feb 27, 2026
Owler
Ionis Pharmaceuticals, Inc.: Ionis Pharmaceuticals's revenue changed from $966.96M in Sep 2025 to $943.71M in Dec 2025
Jan 24, 2026
Pharmabiz
Ionis Pharmaceuticals: Ionis Pharma & Otsuka's donidalorsen gets approval in European Union for hereditary angioedema
Nov 13, 2025
StreetInsider
Press Release: Ionis Pharmaceuticals : Ionis Prices Convertible Notes Offering to Refinance 2026 Convertible Notes
Oct 29, 2025
Owler
Ionis Pharmaceuticals, Inc.: Ionis Pharmaceuticals's revenue changed from $944.05M in Jun 2025 to $966.96M in Sep 2025
Sep 22, 2025
RTTNews
Ionis Pharmaceuticals: Ionis Pharma Reports Positive Topline Results From Pivotal Study Of Zilganersen In Alexander Disease
Sep 22, 2025
Benzinga
Ionis Pharmaceuticals: Ionis Pharmaceuticals Reveals 'Unprecedented Results' From Rare Neurological Disease Trial
Ionis Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10